Stock

Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports

(Reuters) -President-elect Donald Trump met with the chief executives of U.S. drugmakers Pfizer (NYSE:PFE) and Eli Lilly (NYSE:LLY) as well as industry lobbying group PhRMA on Wednesday night, Axios reported on Thursday.

Anti-vaccine activist Robert F. Kennedy Jr., Trump’s pick to lead the United States’ top health agency, was also present at the meeting, according to the report.

A PhRMA spokesperson confirmed that its president and CEO, Stephen Ubl, was present at the dinner, but declined to share any other details.

Eli Lilly and Pfizer did not immediately respond to Reuters’ requests for comment.

Trump and the company executives discussed how the public and private sectors can collaborate on finding cures for cancer, among other topics, at the meeting, which took place at Mar-a-Lago, according to the report.

Mar-a-Lago is the Florida mansion and private club that Trump calls home.

Trump’s incoming chief of staff, Susie Wiles, also attended the meeting, the report added.

This post appeared first on investing.com

You May Also Like

Editor's Pick

Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

Economy

LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

Editor's Pick

Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

Latest News

Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 beneficialinvestmentnow.com

Exit mobile version